51 results
8-K
EX-1.1
NAMS
NewAmsterdam Pharma Company N.V.
9 Aug 24
Other Events
5:23pm
with respect to any Placement Shares not otherwise sold by TD Cowen under this Agreement, except with respect to reimbursement of expenses actually
424B5
NAMS
NewAmsterdam Pharma Company N.V.
9 Aug 24
Prospectus supplement for primary offering
5:21pm
or on terms acceptable to it;
the efficacy and safety of the Company’s product candidate, obicetrapib, as well as potential reimbursement … amounts or on terms acceptable to it;
the efficacy and safety of the Company’s product candidate, obicetrapib, as well as potential reimbursement
S-8
NAMS
NewAmsterdam Pharma Company N.V.
3 Jul 24
Registration of securities for employees
4:34pm
, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken to do so);
in relation to proceedings
S-3
NAMS
NewAmsterdam Pharma Company N.V.
3 Jul 24
Shelf registration
4:31pm
, obicetrapib, as well as potential reimbursement and anticipated market size and market opportunity;
the Company’s dependence on the success … insurance and the relevant insurer has settled, or has provided reimbursement for, these financial losses, damages and expenses (or has irrevocably undertaken
S-3
EX-4.2
wjznc1xjz4z8fwtk
3 Jul 24
Shelf registration
4:31pm
S-3
EX-4.1
2g6avtm5nu07mo74et6
3 Jul 24
Shelf registration
4:31pm
DEF 14A
p8d9cd1
9 May 24
Definitive proxy
4:15pm
10-Q
u66xekioedz8hnxqqr
8 May 24
Quarterly report
4:30pm
PRE 14A
7xyaboc
29 Apr 24
Preliminary proxy
5:00pm
424B3
m7e3ymxp3i
19 Apr 24
Prospectus supplement
4:21pm
POS AM
hrn3uliyug4w9e3
12 Apr 24
Prospectus update (post-effective amendment)
4:15pm
424B3
cjf804 ik
12 Mar 24
Prospectus supplement
4:18pm
POS AM
beq6a0tu
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
10-K
01bs3xy
28 Feb 24
Annual report
8:00am
10-K
EX-10.7
xt0xi8pt ujvki
28 Feb 24
Annual report
8:00am
10-K
EX-10.9
wqxbkvek xmb
28 Feb 24
Annual report
8:00am
10-K
EX-4.4
70wwcj68 14orwo7w9
28 Feb 24
Annual report
8:00am
8-K
EX-1.1
uvxn6rudnwhv4
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
424B5
topy4s31
15 Feb 24
Prospectus supplement for primary offering
4:15pm